NCT03087071 - Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 29, 2017

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

EGFR NP_005219.2:p.S492RKRAS Gene MutationMAP2K1 Gene MutationMetastatic Colorectal AdenocarcinomaRefractory Colorectal AdenocarcinomaStage IV Colorectal Cancer AJCC v7Stage IVA Colorectal Cancer AJCC v7Stage IVB Colorectal Cancer AJCC v7

Interventions

OTHER

Laboratory Biomarker Analysis

Correlative studies

BIOLOGICAL

Panitumumab

Given IV

DRUG

Trametinib

Given PO

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER